GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 17 weeks, 6kg, and cagrilintide was the hard part — 52 comments in the full submission. View in context.
2.3k
c/cagrilintide·submitted 6 months ago by u/lukas_vermeulen

[Results] 17 weeks, 6kg, and cagrilintide was the hard part

Labbranch of 6 comments

17 weeks, 6kg, and cagrilintide was the hard part. Full detail below, and I have tried to keep the editorialising out of it. Pulling the figures out of the title: 17 weeks and 6kg. All of it is written down as it happened rather than reconstructed. Asked a question here that turned out to be based on a mechanism…

Read the full submission and all 52 comments →

This branch

6 comments, started 6 months ago
u/rt_shift_reggie77 points·6 months ago·edited

That is preclinical work and the thread is treating it as a human finding.

replysharereportpermalink
u/tomas_kimani35 points·6 months ago

Same view — long-acting is the engineering achievement here, and it is why the molecule exists at all.

replysharereportpermalink
u/hugo_pires14 points·6 months ago

Yes. The combination is where the interesting effect sizes are, and the monotherapy arms read very differently.

replysharereportpermalink
u/ferran_halonen10 points·6 months ago

Small fix — amylin analogue, not a GLP-1 analogue. The whole mechanism argument changes on that word.

replysharereportpermalink
u/lane_map_larrylogistics8 points·6 months ago·edited

Yes.

Adding the standing caveat — nothing here is approved standalone and research material is not for human use.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.